PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Imperial College, London and Imperial NHS Trust, London, UK. nvergis@ic.ac.uk.\', \'Imperial Clinical Trials Unit and Imperial College, London, UK.\', \'Imperial College, London and Imperial NHS Trust, London, UK.\', \'Newcastle Clinical Trials Unit and Newcastle University, Newcastle upon Tyne, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-021-05190-z
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33845867
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all